论文部分内容阅读
目的：观察生脉注射液辅助治疗充血性心力衰竭（ＣＨＦ）的疗效。方法：１００例ＣＨＦ（不伴高血压）病人，其中５０例（男性２６例，女性２４例；年龄４９±ｓ１３ａ）采用常规疗法（地高辛、氢氯噻嗪、硝酸异山梨酯）作为对照组；５０例（男性２８例，女性２２例；年龄５０±１３ａ）在上述常规治疗基础上加用生脉注射液６０ｍＬ于５％葡萄糖２５０ｍＬ中静脉滴注，ｑｄ，作为治疗组；２组疗程均为１４ｄ。结果：对照组与治疗组依次显效２８％与４６％，总有效率７４％与８８％（Ｐ＜０．０５）。未见不良反应。结论：生脉注射液辅助治疗ＣＨＦ病人可显著提高疗效。
Objective: To observe the effect of Shengmai injection in the treatment of congestive heart failure (CHF). Methods: 100 patients with CHF (without hypertension) were enrolled in this study. 50 of them (26 males and 24 females; age 49 ± s13a) were treated with conventional therapy (digoxin, hydrochlorothiazide and isosorbide dinitrate) Cases (male 28 cases, female 22 cases; age 50 ± 13a) based on the above conventional therapy plus Shengmai injection 60mL in 5% glucose 250mL intravenous infusion, qd, as the treatment group; two treatment groups were 14d . Results: The control group and the treatment group followed by markedly effective 28% and 46%, the total effective rate was 74% and 88% (P <0.05). No adverse reactions. Conclusion: Shengmai injection adjuvant treatment of CHF patients can significantly improve the efficacy.